<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":1928,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
United States ex rel. Feldman v. Van Gorp, 697 F.3d 78 (2d Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/61d2a2954b5af725e121ca5ae1d1bdb3'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/61d2a2954b5af725e121ca5ae1d1bdb3'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1I6PIA003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1I6PIA003">Previous Result: <span>Miller v. Astrue, CIVIL ACTION NO. 3:09-...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1I6PIC003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1I6PIC003">Next Result: <span>Jones v. Daniels, Civil Action Number 3:...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='United States ex rel. Feldman v. Van Gorp, 697 F.3d 78 (2d Cir. 2012), Court Opinion'>
United States ex rel. Feldman v. Van Gorp, 697 F.3d 78 (2d Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>United States ex rel. Feldman v. Van Gorp, 697 F.3d 78 (2d Cir. 2012), Court Opinion</div>
<div class='docId'>X1I6KSO003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>United States ex rel. Feldman v. Van Gorp</div>
<div class='displayCitation'>2012 BL 227268</div>
<div class='displayCitation'>697 F.3d 78</div>
<div class='displayCitation'>bna a0d4m3x0x7</div>
<div class='displayCitation'>wkf2case:26323404</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1I6KSO003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="United States ex rel. Feldman v. Van Gorp, 697 F.3d 78 (2d Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="United States ex rel. Feldman v. Van Gorp" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1I6KSO003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1I6KSO003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1I6KSO003" /><input id="title" name="title" type="hidden" value="United States ex rel. Feldman v. Van Gorp, 697 F.3d 78 (2d Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="61d2a2954b5af725e121ca5ae1d1bdb3" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1I6KSO003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%36%31d%32a%32%39%35%34b%35af%37%32%35e%31%32%31ca%35ae%31d%31bdb%33%2Fdocument%2FX%31I%36KSO%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/bcite/X1I6KSO003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/bcite/X1I6KSO003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/bcite/X1I6KSO003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/related_content/X1I6KSO003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1725130604547";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">697 F.3d 78</div>
<div class="cite" data-cite-type="DocketNumber">Docket Nos. 10-3297(Lead), 11-975(Con).</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 227268</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Second Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
UNITED STATES of America ex rel. Daniel FELDMAN, Plaintiff-Appellee, v.
Wilfred VAN GORP and Cornell University Medical College,
Defendants-Appellants.<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>
</center></p>
<hr align="center" width="65%">
<p><center>
Docket Nos. 10-3297(Lead), 11-975(Con).
</center></p>
<p><center>
Argued: January 30, 2012.
</center></p>
<p><center>
Decided: September 5, 2012.
</center></p>
<p><center>
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> The clerk's office is respectfully directed to amend the official
caption of this case as shown above.
</center></p>
<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the Southern District of
New York, William H. Pauley III, J.
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span CLASS="page_no" data-cite="697 f 3d 79" data-cite-type="PrimaryFederalReporter" data-cite-pageno="79" data-primary-citation="697 F.3d 78">[*79]</span> 
Tracey A. Tiska (R. Brian Black, Eva L. Dietz, on the brief) Hogan Lovells
US LLP, New York, New York, for Defendant-Appellant Cornell University.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Nina M. Beattie, Brune &amp; Richard LLP, New York, NY, for Defendant-Appellant
Wilfred van Gorp.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Michael J. Salmanson (Scott B. Goldshaw, on the brief) Salmanson Goldshaw,
P.C., Philadelphia, PA, for Plaintiff-Appellee.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Jean-David Barnea, Rebecca C. Martin, Sarah S. Normand, Assistant United
States Attorneys, of counsel, for Preet Bharara, United States Attorney for
the Southern District of New York, for Amicus Curiae, The United States of
America.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before: SACK, RAGGI, and CHIN, Circuit Judges.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
SACK, Circuit Judge:
</p></div>
<div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants appeal from a judgment of the United States District Court
for the Southern District of New York (William H. Pauley III, Judge) denying
their motion for judgment as a matter of law and their motion for a new
trial following a jury verdict partially in favor of the plaintiff on his
claims regarding the misuse of a research training grant brought on behalf
of the government pursuant to the False Claims Act, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a><i>et seq.</i>,
and awarding principally $855,714 in treble actual damages. We conclude
that: 1) where
<span CLASS="page_no" data-cite="697 f 3d 80" data-cite-type="PrimaryFederalReporter" data-cite-pageno="80" data-primary-citation="697 F.3d 78">[*80]</span> 
the government has provided funds for a specified good or service only to
have defendant substitute a non-conforming good or service, a court may,
upon a proper finding of False Claims Act liability, calculate damages to be
the full amount of the grant payments made by the government after the
material false statements were made; 2) there was sufficient evidence from
which a reasonable jury could determine that the false statements at issue
were material to the government's funding decision; and 3) the district
court did not abuse its discretion in excluding evidence of inaction on the
part of the National Institutes of Health in response to the plaintiffs
complaint regarding the fellowship program in which he had been enrolled.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>BACKGROUND</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 1997, appellants Cornell University Medical College 3 ("Cornell") and
Dr. Wilfred van Gorp, a professor of psychiatry at Cornell, applied for
funding from the Ruth L. Kirschstein National Research Service Award
Institutional Research Training Grant program, also known as the "T32" grant
program, of the National Institutes of Health ("NIH"). The T32 program funds
pre and post-doctoral training programs in biomedical, behavioral, and
clinical research. T32 grants are meant to "help ensure that a diverse and
highly trained workforce is available to assume leadership roles related to
the Nation's biomedical and behavioral research agenda." NIH Guide, "NIH
National Research Service Award Institutional Research Training Grants," at
1 (May 16, 1997), <i>United States ex rel. Feldman v. Van Gorp</i>, <cite>No. 10-3297</cite>,
Joint Appendix ("J.A.") 2437 (2d Cir. Jan. 26, 2012) ("NIH Guide").
Positions funded through T32 grants may not be used for study leading to
clinically-oriented degrees, "except when those studies are a part of a
formal combined research degree program, such as the M.D./Ph.D." <i></i><cite>Id. at 2</cite>,
J.A. 2438. Instead, funded programs must train their fellows "with the
primary objective of developing or extending their research skills and
knowledge in preparation for a research career." <i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Institutions applying for T32 grants undergo a two-tiered review process.
It begins with a review of the proposal by a twenty-member "Initial Research
Group" ("IRG"), also called a "peer review committee." IRG <span CLASS="page_no" data-cite="2012 bl 227268 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> members are
independent experts in scientific fields related to that of the grant
application under review; they are not NIH employees. Each member scores
applications based on his or her view of its scientific or technical merit
guided by specified criteria, including, among other factors: the program
director's and faculty's training records, as determined by the success of
former trainees; the objective, design, and direction of the program; the
caliber of the faculty; the institutional training environment, including
the commitment of the institution to training and the resources available to
trainees; and the institution's proposed plans for recruiting and selecting
high-quality trainees. The scores are then averaged to arrive at an IRG
"priority score." Testimony of Dr. Robert Bornstein at 1190-91, July 21,
2010 ("Bornstein Testimony"), J.A.1955. This score is included with the IRG
members' written comments in a summary statement, which is transmitted to
the NIH.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The "second tier" of review is performed by the advisory council of the
appropriate constituent organization of the NIH, in this case the National
Institute of Mental Health ("NIMH"). The advisory council ranks the
applications by priority score, and establishes a "pay line" at the point in
the list of applications where there is no
<span CLASS="page_no" data-cite="697 f 3d 81" data-cite-type="PrimaryFederalReporter" data-cite-pageno="81" data-primary-citation="697 F.3d 78">[*81]</span> 
more funding available; only the applications above the "pay line" are
recommended to the director of the funding institute as potential grant
recipients. "The role of the advisory council is not to second-guess the
scientific review of the IRG. Rather, [the council] reviews the applications
to ensure that they further the goals and interests of the awarding
institute. Thus, the IRG review and the resulting high-priority score are
keys to NIH funding." <i></i><cite>Id. at 1190</cite>, J.A.1955-56.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Once an application has placed above the "pay line," the advisory council
makes recommendations based on the scientific merit of the proposal, as
judged by the IRG, and the relevance of the proposal to the awarding
institute's programs and priorities. Funding is typically approved by the
NIH for one year, and recipient institutions are eligible for up to four
years of additional funding.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In order to renew a T32 grant, the recipient institution (in this case
Cornell) must submit an annual renewal application and a progress report
detailing the status of its project. In contrast with initial grant
applications, renewal applications are reviewed solely by the NIH on a
non-competitive basis. The NIH considers the progress made under the grant
and the grant's budget. By regulation, the annual progress report must
contain a "comparison of actual accomplishments with the goals and
objectives established for the period," and must specify "[r]easons why
established goals were not met," if indeed they were not.
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XF5DD8003?jcsearch=45%20C.F.R.%20%2074.51(d)(1)&amp;summary=yes#jcite">45 C.F.R. &sect; 74.51</a>(d)(1)-<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XF5DD8003?jcsearch=45%20C.F.R.%20%2074.51(d)(2)&amp;summary=yes#jcite">(2)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Recipient institutions must also "immediately notify" NIH of "developments
that have a significant impact" on the research program, including
"problems, delays, or adverse conditions which materially impair the ability
to meet the objectives of the award." <i><span CLASS="page_no" data-cite="2012 bl 227268 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> </i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XF5DD8003?jcsearch=45%20C.F.R.%20%2074.51(f)&amp;summary=yes#jcite">Id. &sect; 74.51(f)</a>. This notification must
also include a "statement of the action taken or contemplated, and any
assistance needed to resolve the situation." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XF5DD8003?jcsearch=45%20C.F.R.%20%2074.51(f)&amp;summary=yes#jcite">Id</a>.; see also Draft OIG</i>
<i>Compliance Program Guidance for Recipients of PHS Research Awards</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=70%20federal%20register%2071312&amp;summary=yes#jcite">70 Fed.Reg. 71312-01</a>, 71320 (Nov. 28, 2005) ("Prompt voluntary reporting
will demonstrate the institution's good faith and willingness to work with
governmental authorities to correct and remedy the problem. In addition,
reporting such conduct may be considered a mitigating factor by the
responsible law enforcement or regulatory office. . . .").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Cornell's initial grant application at issue here sought funding for a
fellowship program entitled "Neuropsychology of HIV/AIDS Fellowship." Van
Gorp Grant Application at 1, J.A. 2254 (April 24, 1997) ("Grant
Application"). The application explained that the two-year fellowship would
train as many as six post-doctoral fellows at a time in "child and adult
clinical and research neuropsychology with a strong emphasis upon research
training with HIV/AIDS." <i></i><cite>Id. at 2</cite>, J.A. 2255. The training program would,
according to the application, build on the Cornell faculty's extensive
research into the neuropsychology of HIV/AIDS, which included projects
examining distress levels in HIV-AIDS patients during the course of their
illness, the relationship between the neuropsychology of HIV/AIDS and
patients' abilities to function at work or in school, and the possibility of
using neuropsychological testing to predict whether AIDS patients will
suffer from dementia. The application further explained that van Gorp would
serve as the program director, and that he had a "long history of successful
research, training and mentoring of students in HIV[]related work." <i></i><cite>Id. at
40</cite>, J.A. 2295.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The 123-page grant application outlined the fellowship's curriculum in
detail. Fellows would be required to take "several formal, core didactic
courses," and a number
<span CLASS="page_no" data-cite="697 f 3d 82" data-cite-type="PrimaryFederalReporter" data-cite-pageno="82" data-primary-citation="697 F.3d 78">[*82]</span> 
of elective courses. <i></i><cite>Id. at 45</cite>, J.A. 2300. In the first year of the
fellowship, fellows would enroll in five core courses, some of which "have
been designed specifically for the <b>HIV</b> Neuropsychology Fellowship." <i><cite>Id</cite>.</i>,
J.A. 2300. These core courses would be supplemented by a "large number of
courses, lectures, neuroscience educational programs, as well as other
seminars in a variety of sub-speciality areas." <i><cite>Id</cite>.</i> The curriculum for the
second year, which included four core courses, would allow fellows to
"develop more independent research skills and devote more time to their HIV
research." <i><cite>Id</cite>.</i> The fellows' progress under the grant would be monitored
monthly by a formal training committee comprised of several faculty members,
as "[o]n going evaluation of the curriculum, trainees and faculty is an
integral part of the training program." <i></i><cite>Id. at 48</cite>, J.A. 2303.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Cornell grant application identified a list of fourteen faculty
members who would serve as "Key Personnel," which the NIH defined as
"individuals who contribute to the scientific development or execution of
the project in a substantive way." NIH Grant Application Instructions at 26,
J.A. 2612 (June 8, 1999). The application <span CLASS="page_no" data-cite="2012 bl 227268 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> described in detail some of these
research projects. It also asserted, "Our faculty has a solid track record
in quality and productive research in brain-behavior issues, including
research in HIV/AIDS-related research [sic]." Grant Application at 48, J.A.
2303. And the application identified additional institutions which would
serve as clinical resources, including Cornell University, Memorial
Sloan-Kettering Cancer Center, St. Vincent's Hospital, and Gay Men's Health
Crisis Center.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In describing the fellowship program's commitment to research training,
the grant application explained that "the majority of [the fellows']
clinical work will be with persons with HIV infection." Grant Application at
44, J.A. 2299. Fellows would "devote an average of 75% of their time to
research and an average of 25% [of their] time to clinical work with persons
with HIV/AIDS and other neuropsychiatric disorders." <i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The IRG gave Cornell's grant application a high priority score, and the
NIH subsequently approved funding for two fellows for the fiscal year
beginning September 30, 1997, with the possibility of additional funding for
up to four additional years. Cornell submitted renewal applications in each
of the following four years, from fiscal year 1999 (July 1, 1998, through
June 30, 1999) to fiscal year 2002 (July 1, 2001, through June 30, 2002),
all of which the NIH approved. In the accompanying annual progress reports,
Cornell and van Gorp indicated that there had been no material alterations
to the program as described in the original grant application.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In the renewal application for the second renewal year (the third year
overall), for example, Cornell and van Gorp wrote that "[a]ll core and
supporting faculty listed in our original application are continuing. . . .
There have been no alterations in the courses or training program from that
listed in the original application, except for the addition [specified]
courses. . ." 1999 Progress Report at 7, J.A. 2402 (January 19, 1999). The
renewal application also explained that the program had been relocated from
Cornell's White Plains campus to its New York City (Manhattan) campus in
order to provide fellows with "immediate access to subjects and patients who
have HIV/AIDS." <i><cite>Id</cite>.</i> The renewal applications for the fourth and fifth year
stated that "[t]he core structure of our training program has remained the
same as in years past and to that described in our initial application."
2000 Progress
<span CLASS="page_no" data-cite="697 f 3d 83" data-cite-type="PrimaryFederalReporter" data-cite-pageno="83" data-primary-citation="697 F.3d 78">[*83]</span> 
Report at 4, J.A. 2411 (January 24, 2000); 2001 Progress Report at 5, J.A.
2422 (January 22, 2001). The NIH approved each of these renewal
applications.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In September 1998, at about the time the first renewal-year began, Daniel
Feldman, the plaintiff,<a HREF="#fn100" name="fnref_fn100">[fn1]</a> was selected by Cornell to participate in the
fellowship program. He left the program in December 1999, before the
completion of his two-year fellowship. Other fellows who participated in the
program included Elizabeth Ryan, Clifford Smith, Kimberly Walton Louis, and
Evan Drake. At trial, Feldman presented evidence that the actual fellowship
deviated in many ways from that described in <span CLASS="page_no" data-cite="2012 bl 227268 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> the Grant Application, and that
Cornell and van Gorp failed to inform NIH of these deviations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Testimony presented at trial indicated that some of the faculty members
identified as "Key Personnel" in the initial application did not in fact
contribute in any substantive way to the fellowship program. Van Gorp
acknowledged that the contributions to the program of two of these faculty
members, Dr. Tatsuyki Kakuma and Dr. Michael Giordano, were considerably
limited, if not entirely eliminated, by the fact that the two doctors were
not in physical proximity to the fellows during the grant period. Many
fellows, according to their testimony, had little or no interaction with the
remaining key personnel, and were unaware that these faculty members were or
were supposed to be available as resources. In addition, according to this
testimony, fellows were largely unaware of research opportunities at medical
centers other than Cornell.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There was also testimony in the district court to the effect that Cornell
and van Gorp failed to notify NIH that the curriculum outlined in the
initial grant application was never implemented. Several core courses
identified in the application were not regularly conducted for fellows, and
fellows were not informed that these courses were a required component of
the program. Moreover, according to this testimony, fellows were never
evaluated or supervised by the training committee referred to in the Grant
Application.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Feldman also presented evidence that the research and clinical training
described in the initial grant application differed significantly from the
actual training received. NIH rules provide that fellows in a T32 program
"must devote their, time to the proposed research training and must confine
clinical duties to those that are an integral part of the research training
experience." NIH Guide at 3, J.A. 2439; T32 Training Grant Announcement at
9, J.A. 2568 (June 16, 2006). And, in accordance with these requirements,
the grant application stated that "the majority of [the fellows'] clinical
work will be with persons with HIV infection." Grant Application at 44, J.A.
2299. Further, in explaining the training program's relocation from White
Plains to Manhattan, the third-year renewal application explained that
"[f]ellows [would be] housed within a large, medical/surgical setting with
immediate access to subjects and patients who have HIV/AIDS." 1999 Progress
Report at 7, J.A. 2402.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  But, as the plaintiff summarizes the trial testimony, out of the 165
clinical cases that the fellows saw during their fellowship, only three
involved HIV-positive patients.<a HREF="#fn200" name="fnref_fn200">[fn2]</a>
<span CLASS="page_no" data-cite="697 f 3d 84" data-cite-type="PrimaryFederalReporter" data-cite-pageno="84" data-primary-citation="697 F.3d 78">[*84]</span> 
PL's Br. at 22. Several fellows testified that much of the research that
they performed under the grant program had no relation to HIV or AIDS at
all. For example, Clifford Smith testified that the research projects he
worked on under the T32 grant were primarily related to epilepsy and aging,
and did not involve an HIV population. Out of the eight research projects
that Evan Drake worked on during his fellowship, he said, only one focused
<span CLASS="page_no" data-cite="2012 bl 227268 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> specifically on HIV. Feldman similarly told the court that he worked on only
one HIV-focused project during his time as a fellow.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In July 2001, after he had left the program, Feldman submitted a letter to
the NIH complaining about the program's focus on clinical work rather than
research, and the fellows' limited access to HIV-positive patients. In March
2002, he submitted another letter to the NIH, again complaining that the
fellowship program deviated from its description in the initial grant
application. In response, the NIH asked Cornell to conduct an investigation
of the complaint, which Cornell completed in June 2003. Cornell then sent
Feldman a letter informing him that the investigation uncovered no
wrongdoing.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On October 14, 2003, Feldman filed a <i>qui tarn</i> complaint pursuant to the
False Claims Act ("FCA"), <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a><i>et seq.</i>,<a HREF="#fn300" name="fnref_fn300">[fn3]</a> alleging that
Cornell and van Gorp made false claims to the United States in the Grant
Application and in the four renewal applications. Feldman alleged that
statements made in these applications were false because the fellowship's
curriculum, resources, faculty members, and training differed significantly
from that described in the application, and in the subsequent renewal
applications representing that no changes had been made to the program. The
complaint was unsealed in April 2007, after the United States declined to
intervene in this action. <i>See Cook County v. United States ex rel. Chandler</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XGAU45?jcsearch=538%20us%20119&amp;summary=yes#jcite">538 U.S. 119</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XGAU45?jcsearch=538%20us%20119&amp;summary=yes#jcite">122</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=123%20supreme%20court%201239&amp;summary=yes#jcite">123 S.Ct. 1239</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XGAU45?jcsearch=155%20l%20ed%202d%20247&amp;summary=yes#jcite">155 L.Ed.2d 247</a> (2003) ("The relator must
inform the Department of Justice of her intentions and keep the pleadings
under seal for 60 days while the Government decides whether to intervene and
do its own litigating." (citing <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUI003?jcsearch=31%20U.S.C.%20%203730(b)(2)&amp;summary=yes#jcite">31 U.S.C. &sect; 3730</a>(b)(2)-<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUI003?jcsearch=31%20U.S.C.%20%203730(c)&amp;summary=yes#jcite">(c)</a>)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On January 9, 2009, after discovery had been completed, Cornell and van
Gorp moved for summary judgment. On December 7, 2009, the district court
denied the motion, concluding that there were genuine issues of material
fact as to whether the defendants made false statements
<span CLASS="page_no" data-cite="697 f 3d 85" data-cite-type="PrimaryFederalReporter" data-cite-pageno="85" data-primary-citation="697 F.3d 78">[*85]</span> 
in both the initial grant application and the renewal applications, and
whether those statements were material to the funding decisions. <i>United</i>
<i>States ex rel. Feldman v. Van Gorp ("Feldman I")</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4855H1?jcsearch=674%20f%20supp%202d%20475&amp;summary=yes#jcite">674 F.Supp.2d 475</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4855H1?jcsearch=674%20f%20supp%202d%20475&amp;summary=yes#jcite">482-83</a>
(S.D.N.Y.2009). The district court also concluded that the plaintiff need
not establish actual damages to the government as an element of an FCA claim
because that statute's provision of civil penalties for false and fraudulent
claims allowed courts to "find a violation even in the absence of proof of
damages to the United States." <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4855H1?jcsearch=674%20F.%20Supp.%202d%20475&amp;summary=yes#jcite">Id. at 481</a>. The court did not address,
however, whether Feldman's recovery would be limited to statutory damages.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On December 18, 2009, the defendants moved for reconsideration of the
summary judgment decision, arguing that the district court had erred in
failing to address the issue of whether Feldman should be limited to
statutory penalties because he had not presented sufficient evidence of
actual damages to the United States. On May 3, 2010, the district court
denied the motion, explaining that although the damages to the United States
could not be calculated in the same way they would be in a standard
breach-<span CLASS="page_no" data-cite="2012 bl 227268 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> of-contract action because no tangible benefit had been received, the
plaintiff would not be limited to statutory damages. <i>United States ex rel.</i>
<i>Feldman v. Van Gorp ("Feldman II</i>"), <cite>No. 03 Civ. 8135</cite>, <cite>2010 WL 1948592</cite>, at *1
*2, <cite>2010 U.S. Dist. LEXIS 47039</cite>, at *4-*6 (S.D.N.Y. May 3, 2010). The court
said that the "`benefit of the bargain' to the government is providing funds
to recipients who best fit its specified criteria and that this benefit is
lost when funds are diverted to less eligible recipients." <i><cite>Id</cite>.</i> at *2,
<cite>2010 U.S. Dist. LEXIS 47039</cite>, at *4-*5. Therefore, "if the fact-finder
concludes that the government would not have awarded the grant absent the
false claims, it may properly conclude that the measure of damages is the
total amount the government paid." <i><cite>Id</cite>.</i>, 2010 WL 1948592, at *2,
<cite>2010 U.S. Dist. LEXIS 47039</cite>, at *6.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Before trial, Feldman submitted a motion <i>in limine</i> to exclude evidence
including that of NIH's inaction towards Cornell and van Gorp in response to
Feldman's complaints about the fellowship program. On July 8, 2010, the
district court granted Feldman's motion to exclude that evidence. The court
concluded that the evidence of NIH's inaction was irrelevant and therefore
inadmissible under <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X135KKI003?jcsearch=Fed.%20R.%20Evid.%20402&amp;summary=yes#jcite">Rule 402</a> because "no discovery was conducted concerning
the standards [NIH used] to determine the existence of misconduct and
whether those standards are at all similar to the elements of an FCA claim."
<i>United States ex rel. Feldman v. van Gorp ("Feldman III</i>"), <cite>No. 03 Civ. 8135</cite>,
<cite>2010 WL 2911606</cite>, at *3, <cite>2010 U.S. Dist. LEXIS 73633</cite>, at *7 (S.D.N.Y. July 8,
2010). Moreover, the court concluded, even if "marginally relevant," the
evidence would have been excluded pursuant to <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X135KKK003?jcsearch=Fed.%20R.%20Evid.%20403&amp;summary=yes#jcite">Rule 403</a> because of the
possibility that it would confuse or mislead the jury.<a HREF="#fn400" name="fnref_fn400">[fn4]</a><i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The case was tried to a jury for eight days in July 2010, resulting in a
partial verdict for Feldman. The jury found the defendants not liable for
false statements in the Grant Application and the first renewal application,
but found liability based on the renewal applications for the third, fourth
and fifth years of the grant, i.e., the second, third and fourth renewal
years. On August 3, 2010, the district court awarded actual damages in
treble the amount NIH paid for the last three renewal
<span CLASS="page_no" data-cite="697 f 3d 86" data-cite-type="PrimaryFederalReporter" data-cite-pageno="86" data-primary-citation="697 F.3d 78">[*86]</span> 
years of the grant &mdash; the trebling being provided for in the FCA,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(1)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a)(1) &mdash; totaling $855,714. The judgment also included
statutory penalties of $32,000, for a total of $887,714. The district court
also awarded to the plaintiff $602,898.63 in attorney's fees, $25,862.15 in
costs, and $3,121.47 in expenses.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On August 25, 2010, the defendants filed a motion for judgment as a matter
of law under <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X144L3U003?jcsearch=Fed.%20R.%20Civ.%20P%2050(b)&amp;summary=yes#jcite">Rule 50(b)</a>, or in the alternative, for a new trial pursuant to
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X144L4I003?jcsearch=Fed.%20R.%20Civ.%20P%2059&amp;summary=yes#jcite">Rule 59</a>. The defendants argued that there was insufficient evidence from
which the jury could properly have concluded that the false statements at
issue were material to the NIH's decisions to renew the T32 grant, and that
the court should grant judgment as a matter of law, or that such a
conclusion was against the weight of the evidence and warranted a new trial.
The defendants also argued that the district court erred in determining as a
matter of law that damages were equal to the entire grant amounts for the
years in which liability was found rather than submitting that <span CLASS="page_no" data-cite="2012 bl 227268 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> question to
the jury.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court denied this motion on December 9, 2010. <i>United States</i>
<i>ex rel. Feldman v. van Gorp ("Feldman IV</i>"), <cite>No. 03 Civ. 8135</cite>,
[<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">2010 BL 292231</a>], 2010 WL 5094402, at *5, <a>2010 U.S. Dist. LEXIS 130358</a>, at *14-*15 (S.D.N.Y.
Dec. 9, 2010). The court concluded that Feldman had presented sufficient
evidence for the jury to conclude that the false statements were material to
the NIH's funding decisions, noting that NIH's guidelines and instructions
on the renewal applications unambiguously stated that it should be notified
of any changes made to the grant program. <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i> at *2-*5,
<a>2010 U.S. Dist. LEXIS 130358</a>, at *4-*14. The district court also relied on
its opinion in <i>Feldman III</i> to deny the motion for a jury trial on damages.
<i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i> at *5, <a>2010 U.S. Dist. LEXIS 130358</a>, at *13-*15.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>DISCUSSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants contend that: (1) the district court erred in its
methodology for determining damages and in determining the amount of those
damages, as a matter of law; (2) the jury did not have sufficient evidence
from which to conclude that the false statements at issue were material to
the funding decision; and (3) the district court erred in excluding evidence
of NIH's "inaction" in response to Feldman's complaint.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I. Damages
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The False Claims Act prohibits a person from "knowingly present[ing], or
caus[ing] to be presented, [to an officer or employee of the United States
Government,] a false or fraudulent claim for payment or approval."
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(1)(A)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a)(1)(A). Liability under the Act also requires a showing
of materiality.<a HREF="#fn500" name="fnref_fn500">[fn5]</a> Under the Act as currently in force, "the term
`material' means having a natural tendency to influence, or be capable of
influencing, the payment or receipt of money or property." <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(b)(4)&amp;summary=yes#jcite">Id. &sect; 3729(b)(4)</a>;
<i>see also Neder v. United States</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X2TB69?jcsearch=527%20us%201&amp;summary=yes#jcite">527 U.S. 1</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X2TB69?jcsearch=527%20us%201&amp;summary=yes#jcite">16</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=119%20supreme%20court%201827&amp;summary=yes#jcite">119 S.Ct. 1827</a>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X2TB69?jcsearch=144%20l%20ed%202d%2035&amp;summary=yes#jcite">144 L.Ed.2d 35</a> (1999) ("In
<span CLASS="page_no" data-cite="697 f 3d 87" data-cite-type="PrimaryFederalReporter" data-cite-pageno="87" data-primary-citation="697 F.3d 78">[*87]</span> 
general, a false statement is material if it has a natural tendency to
influence, or [is] capable of influencing, the decision of the
decisionmaking body to which it was addressed." (brackets in original;
internal quotation marks omitted) (criminal fraud case)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The FCA provides for damages equal to "3 times the amount of damages which
the Government sustains because of the act of that person," in addition to a
"civil penalty." <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(1)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a)(1). The Act does not specify how
damages are to be calculated, but the Supreme Court has recognized that the
purpose of damages, even as multiplied, under the Act is to make the
government "completely whole" for money taken from it by fraud. <i>United</i>
<i>States ex. rel. Marcus v. Hess</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X5C0GP?jcsearch=317%20us%20537&amp;summary=yes#jcite">317 U.S. 537</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X5C0GP?jcsearch=317%20us%20537&amp;summary=yes#jcite">551-52</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=63%20supreme%20court%20379&amp;summary=yes#jcite">63 S.Ct. 379</a>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X5C0GP?jcsearch=87%20l%20ed%20443&amp;summary=yes#jcite">87 L.Ed. 443</a> (1943), <i>superseded by statute as recognized by United States ex</i>
<i>rel. Kirk v. Schindler Elevator Corp.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1CVCR0003?jcsearch=601%20f%203d%2094&amp;summary=yes#jcite">601 F.3d 94</a> (2d Cir.2010) ("We think
the chief purpose of the statutes here [predecessors of the current False
Claims Act, providing for double rather than treble damages] was to provide
for restitution to the government of money taken from it by fraud, and that
the device of double damages plus a specific sum was chosen to make sure
that the government would be made completely whole."). Because the district
court here determined that damages could be established as a matter of law,
we review that conclusion <i>de novo. See Bessemer Trust Co., N.A. v. Branin</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1E38KS003?jcsearch=618%20f%203d%2076&amp;summary=yes#jcite">618 F.3d 76</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1E38KS003?jcsearch=618%20f%203d%2076&amp;summary=yes#jcite">85</a> (2d Cir.2010) (stating that where the district court has
determined damages, we review its application of legal principles <i>de novo<span CLASS="page_no" data-cite="2012 bl 227268 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> </i>
and its factual findings for clear error).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The question of how damages should be measured in an FCA case where
"contracts entered into between the government and the Defendants did not
produce a tangible benefit to the [government]," <i>United States ex. rel.</i>
<i>Longhi v. United States</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1BAK9C003?jcsearch=575%20f%203d%20458&amp;summary=yes#jcite">575 F.3d 458</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1BAK9C003?jcsearch=575%20f%203d%20458&amp;summary=yes#jcite">473</a> (5th Cir.2009), is one of first
impression in this Court. The defendants argue both that the district court
erred in concluding that application of the standard benefit-of-the-bargain
calculation as a methodology for determining damages was inappropriate in
this case, and that it erred in deciding the amount of damages as a matter
of law based on the jury's verdict, rather than allowing the jury to assess
the amount of damages due.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>A. Proper Measure of Damages</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In most FCA cases, damages are measured as they would be in a
run-of-the-mine breach-of-contract case &mdash; using a "benefit-of-the-bargain"
calculation in which a determination is made of the difference between the
value that the government received and the amount that it paid. <i>See United</i>
<i>States v. Foster Wheeler Corp.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X3TIVL?jcsearch=447%20f%202d%20100&amp;summary=yes#jcite">447 F.2d 100</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X3TIVL?jcsearch=447%20f%202d%20100&amp;summary=yes#jcite">102</a> (2d Cir.1971) (collecting
cases); <i>cf. Terwilliger v. Terwilliger</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X3F97A?jcsearch=206%20f%203d%20240&amp;summary=yes#jcite">206 F.3d 240</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X3F97A?jcsearch=206%20f%203d%20240&amp;summary=yes#jcite">248</a> (2d Cir.2000)
("[S]o far as possible, [New York contract] law attempts to secure to the
injured party the benefit of his bargain, subject to the limitations that
the injury &mdash; whether it be losses suffered or gains prevented &mdash; was
foreseeable, and that the amount of damages claimed be measurable with a
reasonable degree of certainty and, of course, adequately proven." (internal
quotation marks omitted)). This method of calculation is employed, for
example, when the government has paid for goods or services that return a
tangible benefit to the government.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There are generally two ways of determining damages in such cases. First,
if the non-conforming goods or services have an ascertainable market value,
then damages are measured according to the "`difference between the market
value of the product [the government] received and retained
<span CLASS="page_no" data-cite="697 f 3d 88" data-cite-type="PrimaryFederalReporter" data-cite-pageno="88" data-primary-citation="697 F.3d 78">[*88]</span> 
and the market value that the product would have had if it had been of the
specified quality.'" <i>United States v. Science Applications Int'l Corp.</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1ELTV4003?jcsearch=626%20f%203d%201257&amp;summary=yes#jcite">626 F.3d 1257</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1ELTV4003?jcsearch=626%20f%203d%201257&amp;summary=yes#jcite">1279</a> (D.C.Cir.2010) (quoting <i>United States v. Bornstein</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X5C92G?jcsearch=423%20us%20303&amp;summary=yes#jcite">423 U.S. 303</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X5C92G?jcsearch=423%20us%20303&amp;summary=yes#jcite">316</a> n. 13, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=96%20supreme%20court%20523&amp;summary=yes#jcite">96 S.Ct. 523</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X5C92G?jcsearch=46%20l%20ed%202d%20514&amp;summary=yes#jcite">46 L.Ed.2d 514</a> (1976)) (alterations
omitted). If the non-conforming goods' or services' market value is not
ascertainable, then the fact-finder determines the amount of damages by
calculating the difference between "the amount the government actually paid
minus the value of the goods or services the government received or used,"
as judged by the fact-finder. <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1ELTV4003?jcsearch=626%20F.3d%201257&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants contend that a "benefit-of-the-bargain" calculation was
appropriate in this case, and that the district court erred by awarding the
government the full amount of the grant for the years for which the
violations were found rather than the difference between the value of the
training promised and that actually delivered. The plaintiff argues, to the
contrary, that a different measure of damages is appropriate in cases such
as this, where "the defendant fraudulently sought payments for participating
in programs designed to benefit third-parties rather than the government
<span CLASS="page_no" data-cite="2012 bl 227268 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> itself and the government received nothing of tangible value from the
defendant. <i>Id.; see also Longhi</i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1BAK9C003?jcsearch=575%20f%203d%20458&amp;summary=yes#jcite">575 F.3d at 473</a> ("[W]here there is no
tangible benefit to the government and the intangible benefit is impossible
to calculate, it is appropriate to value damages in the amount the
government actually paid to the Defendants."). This approach rests on the
notion that the government receives nothing of measurable value when the
third-party to whom the benefits of a governmental grant flow uses the grant
for activities other than those for which funding was approved. In other
words, when a third-party successfully uses a false claim regarding how a
grant will be used in order to obtain the grant, the government has entirely
lost its opportunity to award the grant money to a recipient who would have
used the money as the government intended.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The plaintiff and the United States, as <i>amicus curiae</i>, argue that this is
such a case: The government received no tangible benefit from the T32 grant
&mdash; students and others may have, but not the government. The grant
represented an attempt to, but did not thereby, promote "child and adult
clinical and research neuropsychology with a strong emphasis upon research
training with HIV/AIDS." Grant Application at 2, J.A. 2255. The plaintiff
argues that the government is therefore entitled to damages equal to the
full amount of grants awarded to the defendants based on their false
statements.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We conclude that the measure of damages advocated by the plaintiff and the
United States is correct.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although we have not addressed this question, several of our sister
circuits have done so in decisions that support the conclusion we now reach.
<i>See Science Applications</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1ELTV4003?jcsearch=626%20f%203d%201257&amp;summary=yes#jcite">626 F.3d at 1279</a> (D.C.Cir.); <i>Longhi</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1BAK9C003?jcsearch=575%20f%203d%20458&amp;summary=yes#jcite">575 F.3d at 473</a> (5th Cir.); <i>United States v. Rogan</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X18I3JQ003?jcsearch=517%20f%203d%20449&amp;summary=yes#jcite">517 F.3d 449</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X18I3JQ003?jcsearch=517%20f%203d%20449&amp;summary=yes#jcite">453</a> (7th
Cir.2008) ("The government offers a subsidy . . . with conditions. When the
conditions are not satisfied, nothing is due."); <i>United States v. Mackby</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X6A0SR?jcsearch=339%20f%203d%201013&amp;summary=yes#jcite">339 F.3d 1013</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X6A0SR?jcsearch=339%20f%203d%201013&amp;summary=yes#jcite">1018-19</a> (9th Cir.2003) ("Had Mackby been truthful, the
government would have known that he was entitled to nothing. . . .").<a HREF="#fn600" name="fnref_fn600">[fn6]</a>
</p></div>
<span CLASS="page_no" data-cite="697 f 3d 89" data-cite-type="PrimaryFederalReporter" data-cite-pageno="89" data-primary-citation="697 F.3d 78">[*89]</span> <div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants point out, however, that other courts have applied the
"benefit-of-the-bargain" calculation in cases they assert are similar to
this one. They argue that because "[t]he ultimate beneficiary of all
government grants or contracts is the public regardless of who receives the
`direct' benefit," the flow of benefits to a third-party should not be
determinative of the damages measure. Defs.' Reply Br. at 5.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In support of this theory, the defendants cite <i>United States v. Hibbs</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X3U9ID?jcsearch=568%20f%202d%20347&amp;summary=yes#jcite">568 F.2d 347</a> (3d Cir.1977). There, the Third Circuit applied a
benefit-of-the-bargain calculation in an FCA case involving the defendants'
fraudulent statements to the Federal Housing Administration regarding the
condition of various residential properties. Relying on these
representations, the agency insured mortgages on several properties, and the
agency was required to pay these mortgages when the purchasers defaulted.
<i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X3U9ID?jcsearch=568%20F.2d%20347&amp;summary=yes#jcite">Id. at 349</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The government argued that its damages were the total amount of the
mortgage debt it had assumed, insisting that "had [the defendant] not
furnished the false certification, it would <span CLASS="page_no" data-cite="2012 bl 227268 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> not have insured the mortgage[s]
and therefore would not have been called upon to make any payment." <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X3U9ID?jcsearch=568%20F.2d%20347&amp;summary=yes#jcite">Id. at
351</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Third Circuit rejected this argument.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      The government's actual damage was the decrease in worth of the
    security that was certified as being available, measured by the
    difference in value between the houses as falsely represented, and
    as they actually were. Since the government was given security which
    was less than what it was represented to be, the damages are
    essentially similar to those sustained when a defective article is
    purchased in a fraudulent transaction. In those instances,
    decisional law sets the damages as the difference in cost between
    that contracted for and that received.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X3U9ID?jcsearch=568%20F.2d%20347&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Similarly, in <i>Coleman v. Hernandez</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1FLM8N?jcsearch=490%20f%20supp%202d%20278&amp;summary=yes#jcite">490 F.Supp.2d 278</a> (D.Conn.2007), a
case involving the so-called "Housing Choice Voucher Program" or "<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEJAT8003?jcsearch=42%20U.S.C.%201437f&amp;summary=yes#jcite">Section
8</a>," under which the government provides housing subsidies to qualifying
individuals, the district court declined to award the plaintiff the full
amount that the government paid to subsidize her rent, even though her
landlord had allegedly made false statements to the government by
overcharging the plaintiff for rent. <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1FLM8N?jcsearch=490%20F.%20Supp.%202d%20278&amp;summary=yes#jcite">Id. at 280-83</a>. The <i>Coleman</i> court
acknowledged that in other FCA cases, courts had awarded damages equal to
the full amount of the government's payment. <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1FLM8N?jcsearch=490%20F.%20Supp.%202d%20278&amp;summary=yes#jcite">Id. at 281-82</a>. But the court
decided that in the case before it, the awardable damages were equal to the
difference between the market rent, and the amount that the landlord charged
the government including the additional, improper payments it had received,
i.e., the amount of the overcharge. <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1FLM8N?jcsearch=490%20F.%20Supp.%202d%20278&amp;summary=yes#jcite">Id. at 282</a>. The government was then made
whole, receiving the full benefit of its bargain &mdash; trebled by statute.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span CLASS="page_no" data-cite="697 f 3d 90" data-cite-type="PrimaryFederalReporter" data-cite-pageno="90" data-primary-citation="697 F.3d 78">[*90]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants also look to Medicaid and Medicare FCA cases for support.
They contend that adopting the plaintiff's theory of damages, all such cases
would result in damages equal to the full amount the government paid in
reimbursements to physicians because "the direct benefit always goes to
patients." Defs.' Reply Br. at 5.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This is not, however, the methodology generally employed by courts
evaluating FCA claims based on Medicaid or Medicare fraud. In <i>United States</i>
<i>ex. rel. Tyson v. Amerigroup Illinois, Inc.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X16FN9U003?jcsearch=488%20f%20supp%202d%20719&amp;summary=yes#jcite">488 F.Supp.2d 719</a>
(N.D.I.11.2007), the court awarded damages based on the difference between
the amount of Medicare payments that the defendant should have received, and
the amount that it had actually charged the government. <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X16FN9U003?jcsearch=488%20F.%20Supp.%202d%20719&amp;summary=yes#jcite">Id. at 739</a>.
Similarly, in <i>United States ex. rel. Doe v. DeGregorio</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X16OLKK003?jcsearch=510%20f%20supp%202d%20877&amp;summary=yes#jcite">510 F.Supp.2d 877</a>
(M.D.Fla. 2007), the court also held that damages were the "the amount of
money the government paid out by reason of the false claims over and above
what it would have paid out if the claims had not been false." <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X16OLKK003?jcsearch=510%20F.%20Supp.%202d%20877&amp;summary=yes#jcite">Id. at 890</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In short, in each of the cases cited by the defendants, the government
paid for a contracted service with a tangible benefit &mdash; whether it be
medical care, security on mortgages, or subsidized housing &mdash; but paid too
much. The government in these cases got what it bargained for, but it did
not get <i>all</i> that it bargained for. Thus, courts treated the difference
between what the government <span CLASS="page_no" data-cite="2012 bl 227268 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[**12]</span> bargained for and what it actually received as
the measure of damages. Here, by contrast, the government bargained for
something qualitatively, but not quantifiably, different from what it
received.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This approach comports with the one we discussed in making a sentencing
calculation of loss in <i>United States v. Canova</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNEOQ4II8BG0?jcsearch=412%20f%203d%20331&amp;summary=yes#jcite">412 F.3d 331</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNEOQ4II8BG0?jcsearch=412%20f%203d%20331&amp;summary=yes#jcite">352</a> (2005)
(rejecting argument that abbreviated medical tests performed by the
defendant were as clinically sound as full tests required by Medicare so
that the government sustained no loss). There, we explained that it was not
a court's task to second-guess a victim's judgment as to the necessity of
specifications demanded and paid for. <i>See <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNEOQ4II8BG0?jcsearch=412%20F.3d%20331&amp;summary=yes#jcite">id</a>.</i> ("Whether the testing time on
a pacemaker, the number of rivets on an airplane wing, or the coats of paint
on a refurbished building is a matter of necessity or whim, the fact remains
that the victim has been induced to pay for something that it wanted and was
promised but did not get, thereby incurring some measure of pecuniary
`loss.'") To be sure, <i>Canova</i> recognized that "a victim's loss in a
substitute goods or services case" does not "necessarily equal[] the full
contract price paid." <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNEOQ4II8BG0?jcsearch=412%20F.3d%20331&amp;summary=yes#jcite">Id. at 353</a>. But this was not because a defendant had
the right to an offset for the value of the substituted good or service.
Rather, the proper focus of any loss calculation was on "the `reasonably
foreseeable costs of making substitute transactions and handling or
disposing of the product delivered or retrofitting the product so that it
can be used for its intended purpose,' plus the `reasonably foreseeable cost
of rectifying the actual or potential disruption to [the victim's]
operations caused by the product substitution.'" <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNEOQ4II8BG0?jcsearch=412%20F.3d%20331&amp;summary=yes#jcite">Id</a>.</i> (quoting U.S.S.G. <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=U.S.%20Sentencing%20Guidelines%20Manual%20%202f1.1&amp;summary=yes#jcite">&sect;
2f1.1</a>, cmt. n.8(c)). <i>Canova</i> emphasized that a court calculating loss cannot
simply "rewrit[e] the parties' contract to excise specifications paid for
but not received and, thereby, conclud[e] that the victim sustained no [or a
reduced] loss." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNEOQ4II8BG0?jcsearch=412%20F.3d%20331&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>Canova's</i>, reasoning supports the challenged loss calculation. As a result
of the fraudulent renewals, the government was paying for a program that was
not at all as specified. By contrast to the Medicare cases cited by
defendants, the government
<span CLASS="page_no" data-cite="697 f 3d 91" data-cite-type="PrimaryFederalReporter" data-cite-pageno="91" data-primary-citation="697 F.3d 78">[*91]</span> 
did not receive less than it bargained for; it did not get the
"neuropsychology with a strong emphasis upon research training with
HIV/AIDS" program it bargained for at all. Further, nothing in the record
indicates that it could now secure such a program at any lesser cost. We
therefore conclude that the appropriate measure of damages in this case is
the full amount the government paid based on materially false statements.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>B. Fraudulent Inducement</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants acknowledge that courts have applied the plaintiffs theory
of damages in cases including <i>Mackby, Rogan</i>, and <i>Longhi</i> but argue that those
cases are distinguishable from this one because the defendants in each of
those cases obtained funds through fraudulent inducement &mdash; and that any such
theory would fail here because no liability was found with respect to the
Grant Application. "In a fraudulent inducement case, [it is] the false
<span CLASS="page_no" data-cite="2012 bl 227268 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[**13]</span> statements [that] allow the defendant to obtain the funding in the first
place." Defs.' Reply Br. at 9.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  According to the defendants, because a defendant in a fraudulent
inducement case would not be eligible for <i>any</i> funding received after the
initial false claim, a court in such a case could properly conclude that the
defendant is liable for the entire amount that the government paid. But
"[h]ere, the jury expressly found that the initial Application contained no
false statements, and there was no false certification ever at issue." <i><cite>Id</cite>.</i>
The defendants argue that <i>Mackby, Rogan</i>, and <i>Longhi</i> therefore do not support
the damages theory employed by the district court.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We see no principled distinction, however, between fraudulently inducing
payment initially, thereby requiring all payments produced from that initial
fraud to be returned to the government (trebled and with certain fees and
costs added as provided by statute), and requiring payments based on false
statements to be returned to the government when those false statements were
made after an initial contractual relationship based on truthful statements
had been established. Although it may be true that under a fraudulent
inducement theory, "subsequent claims for payment made under the contract
[that] were not literally false, [because] they derived from the original
fraudulent misrepresentation, [are also] . . . actionable false claims,"
<i>Longhi</i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1BAK9C003?jcsearch=575%20f%203d%20458&amp;summary=yes#jcite">575 F.3d at 468</a> (second brackets in original; internal quotation marks
omitted), this proposition simply speaks to the time period for which FCA
liability may be found. It does not suggest that without fraudulent
inducement, no subsequent false statements can result in FCA liability.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  If the government made payment based on a false statement, then that is
enough for liability in an FCA case, regardless of whether that false
statement comes at the beginning of a contractual relationship or later. The
only difference would be that liability begins when the false statement is
made and relied upon, rather than at the beginning of the contractual
relationship, as it would be in a fraudulent inducement case. Here, the jury
found that materially false statements had been made by the defendants in
years 3, 4, and 5 of the grant, and the court properly awarded damages based
on that finding.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>C. Damages as a Matter of Law</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants argue that the calculation of damages should have been
decided as a question of fact by a jury, not as a matter of law by the
district court. Indeed, in FCA cases, the jury ordinarily does determine the
amount of damages to be imposed upon the defendant. <i>See Chandler</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XGAU45?jcsearch=538%20us%20119&amp;summary=yes#jcite">538 U.S. at 132</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=123%20supreme%20court%201239&amp;summary=yes#jcite">123 S.Ct. 1239</a>. We
<span CLASS="page_no" data-cite="697 f 3d 92" data-cite-type="PrimaryFederalReporter" data-cite-pageno="92" data-primary-citation="697 F.3d 78">[*92]</span> 
conclude, however, that here, where the question is not the benefit of the
bargain between the plaintiff and the defendants, and the amount of each
payment for which liability has been assessed is not in dispute, no further
finding of fact as to the amount of the damages was necessary.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As the government correctly observes in its <i>amicus</i> brief, awarding damages
in this manner is not novel. And often, the amount of damages in such cases
has been determined as a matter <span CLASS="page_no" data-cite="2012 bl 227268 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[**14]</span> of law in the course of the court's grant of
summary judgment to the plaintiff. <i>See, e.g., Longhi</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1BAK9C003?jcsearch=575%20f%203d%20458&amp;summary=yes#jcite">575 F.3d at 461</a>
(affirming summary judgment and damages award); <i>United States v. TDC Mgmt.</i>
<i>Corp.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4IU8I?jcsearch=288%20f%203d%20421&amp;summary=yes#jcite">288 F.3d 421</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4IU8I?jcsearch=288%20f%203d%20421&amp;summary=yes#jcite">428</a> (D.C.Cir.2002) (agreeing that the district court
could properly decide the damages award where the government received no
benefit from the transaction).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>United States ex rel. Antidiscrimination Center of Metro New York, Inc. v.</i>
<i>Westchester County</i>, <cite>No. 06 Civ. 2860</cite>, [<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1AKFV2003?jcsearch=668%20F.%20Supp.%202d%20548&amp;summary=yes#jcite">668 F. SUPP. 2D 548</a>], 2009 WL 1108517,
<a>2009 U.S. Dist. LEXIS 35041</a> (S.D.N.Y. Apr. 24, 2009), is illustrative. There
the federal government paid approximately $52 million as part of a federal
grant to Westchester County for the purposes of housing and community
development. <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1AKFV2003?jcsearch=668%20F.%20Supp.%202d%20548&amp;summary=yes#jcite">Id</a>.</i> at *2-*4, <a>2009 U.S. Dist. LEXIS 35041</a>, at *5-*11. The grant
required the county to certify that it would "conduct an analysis of
impediments . . . to fair housing choice, including those impediments
imposed by racial discrimination and segregation, to take appropriate
actions to overcome the effects of any identified impediments, and to
maintain records reflecting the analysis and actions." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1AKFV2003?jcsearch=668%20F.%20Supp.%202d%20548&amp;summary=yes#jcite">Id</a>.</i> at *1,
<a>2009 U.S. Dist. LEXIS 35041</a>, at *2-*3. The court granted summary judgment
for the plaintiff after finding that Westchester County had not conducted
the analysis as promised. The court agreed with the plaintiffs contention
that damages should be the full amount the government paid, and rejected the
county's argument that the damages question should be submitted to the jury.
There, as here, "the United States did not get what it paid for," and there
was no role for the jury because "Westchester's damages cannot be reduced by
reference to the alleged `benefit' it provided to HUD." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1AKFV2003?jcsearch=668%20F.%20Supp.%202d%20548&amp;summary=yes#jcite">Id</a>.</i> at *3,
<a>2009 U.S. Dist. LEXIS 35041</a>, at *9.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We conclude that in the case before us, inasmuch as the damages equal the
full amount that the government paid and that amount is not in dispute, they
were properly determined by the district court as a matter of law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>D. Sufficiency of the Evidence</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, the defendants contend that the plaintiff did not submit
sufficient evidence to the jury to establish by a preponderance of the
evidence that the government suffered damages equal to the full amount of
the T32 grant. The defendants argue that "to prove that the amount of
damages was the entire amount of the grant, a relator would be required to
prove that the government received no value &mdash; at all &mdash; through the grant
work it funded." Defs.' Br. at 37.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants support this contention by citing benefit-of-the-bargain
cases. The defendants' argument is therefore unavailing. Unlike a
benefit-of-the-bargain case, no specific amount of damages must be proved
because, as we have explained at length, damages in this case equal the
entire amount of the grant that was lost as a result of the fraud.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  II. Materiality
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants assert that the false statements to the government that are
at issue were not material to the transactions in question. The district
court therefore erred, they say, in denying the defendants'
<span CLASS="page_no" data-cite="697 f 3d 93" data-cite-type="PrimaryFederalReporter" data-cite-pageno="93" data-primary-citation="697 F.3d 78">[*93]</span> 
motion for judgment as a matter of law and for a new trial.<a HREF="#fn700" name="fnref_fn700">[fn7]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We conclude that the jury had sufficient evidence from which to conclude,
as it did, that the defendants' false statements materially influenced NIH's
decisions to renew <span CLASS="page_no" data-cite="2012 bl 227268 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[**15]</span> the T32 grant.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A motion for a new trial will ordinarily be granted "so long as the
district court determines that, in its independent judgment, the jury has
reached a seriously erroneous result or [its] verdict is a miscarriage of
justice." <i>Nimely v. City of New York</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNET90II8BG0?jcsearch=414%20f%203d%20381&amp;summary=yes#jcite">414 F.3d 381</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNET90II8BG0?jcsearch=414%20f%203d%20381&amp;summary=yes#jcite">392</a> (2d Cir.2005)
(internal quotation marks omitted). We review the district court's denial of
a motion for a new trial for abuse of discretion. <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNET90II8BG0?jcsearch=414%20F.3d%20381&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A motion for judgment as a matter of law may be granted only "[i]f a party
has been fully heard on an issue during a jury trial and the court finds
that a reasonable jury would not have a legally sufficient evidentiary basis
to find for the party on that issue." Fed.R.Civ.P. <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X144L3U003?jcsearch=Fed.%20R.%20Civ.%20P.%2050(a)(1)&amp;summary=yes#jcite">50</a>(a)(1). "A court
evaluating such a motion cannot assess the weight of conflicting evidence,
pass on the credibility of witnesses, or substitute its judgment for that of
the jury." <i>Black v. Finantra Capital, Inc.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X12LCKG003?jcsearch=418%20f%203d%20203&amp;summary=yes#jcite">418 F.3d 203</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X12LCKG003?jcsearch=418%20f%203d%20203&amp;summary=yes#jcite">209</a> (2d Cir.2005)
(internal quotation marks omitted). Because such a judgment is made as a
matter of law, we review it <i>de novo.</i> We must "consider the evidence in the
light most favorable to the party against whom the motion was made and . . .
give that party the benefit of all reasonable inferences that the jury might
have drawn in his favor from the evidence." <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X12LCKG003?jcsearch=418%20F.3d%20203&amp;summary=yes#jcite">Id. at 208-09</a> (internal
quotation marks omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court concluded that the plaintiff had "presented significant
documentary evidence to support a finding of materiality." <i>Feldman IV</i>,
[<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">2010 BL 292231</a>], 2010 WL 5094402, at *2, <a>2010 U.S. Dist. LEXIS 130358</a>, at *5.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, the parties stipulated that in order for a grantee to receive
additional funding after the initial grant year, the "grantee must submit a
noncompetitive renewal application . . . includin[g] a progress report which
NIH expects will provide information about the trainees['] activities during
the previous funding period." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i> Second, the renewal instructions for the
T32 grant contain a statement explaining that "`Progress Reports provide
information to awarding component staff that is essential in the assessment
of changes in scope or research objectives . . . from those actually funded.
They are also an important information source for the awarding component
staff in preparing annual reports, in planning programs, and in
communicating scientific accomplishments to the public and to Congress.'"
<i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i>, 2010 WL 5094402, at *2, <a>2010 U.S. Dist. LEXIS 130358</a>, at *6 (quoting
NIH Grant Continuation Instructions at 7, J.A. 2462). Third, the renewal
instructions direct grantees to "highlight progress in implementation and
developments or changes that have occurred. Note any difficulties
encountered by the program. Describe changes in the program for the next
budget period, including changes in training faculty and significant changes
in available space and/or facilities." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i> (internal quotation marks and
brackets omitted). The instructions also ask for "`information describing
which, if any, faculty and/or mentors have left the program.'" <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i> at *3,
<a>2010 U.S. Dist. LEXIS 130358</a>, at *6-*7 (quoting T32 Program Announcement
<span CLASS="page_no" data-cite="697 f 3d 94" data-cite-type="PrimaryFederalReporter" data-cite-pageno="94" data-primary-citation="697 F.3d 78">[*94]</span> 
PA-06-648 at 22, J.A. 2581 (June 16, 2006)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court rejected the defendants' argument that the jury was
required to accept Dr. Robert Bornstein's unrebutted testimony on the issue
of materiality. <span CLASS="page_no" data-cite="2012 bl 227268 p 16" data-cite-type="Bloomberg" data-cite-pageno="16" data-primary-citation="">[**16]</span> <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i>, 2010 WL 5094402, at *3, <a>2010 U.S. Dist. LEXIS 130358</a>,
at *7. Bornstein was a member of the IRG that reviewed the defendants'
initial grant application. At trial, he testified as to the factors he
considered material to his analysis of a grant application. He asserted that
although he reviewed the application, he did not expect that every faculty
member identified in the initial grant application would be involved with
the fellowship program. He also testified that he did not expect the
fellowship program to follow the exact curriculum outlined in the initial
application. The defendants argued that this testimony established that not
all false statements in the renewal applications were material.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court rejected this argument because Bornstein never reviewed
the renewal applications, nor did he have an independent recollection of
reviewing the initial grant application. <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i>, 2010 WL 5094402, at *3,
<a>2010 U.S. Dist. LEXIS 130358</a>, at *7-*8. The court also concluded that "[t]he
absence of testimony by a government official supporting a finding of
materiality does not mean that the jury was required to accept Bornstein's
testimony." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i>, 2010 WL 5094402, at *3, <a>2010 U.S. Dist. LEXIS 130358</a>, at
*7. "[T]he jury was well within its bounds to credit NIH's unambiguous
guidelines and instructions over Bornstein's conclusory testimony that
little in the Grant Application really would have mattered to him had he
remembered reviewing it at all." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1EMQ8S003?jcsearch=2010%20BL%20292231&amp;summary=yes#jcite">Id</a>.</i>, 2010 WL 5094402, at *3,
<a>2010 U.S. Dist. LEXIS 130358</a>, at *8.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On appeal, the defendants do not dispute that the renewal applications
contained NIH's instructions and guidelines. They contend instead that "none
of these statements, taken individually or together, establish what
information was material to NIH's funding decisions on renewals," Defs.' Br.
at 47, "the Renewal Instructions and the Program Announcement are silent as
to what information matters to NIH for purposes of its funding decision."
<i></i><cite>Id. at 52</cite>. The defendants argue in substance that there is no evidence from
which the jury could have decided that the statements it found to be false
materially influenced NIH's decision to renew the T32 grant.<a HREF="#fn800" name="fnref_fn800">[fn8]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This argument, however, misapprehends the focus of the materiality
analysis. In <i>Rogan</i>, the defendant hospital admitted
<span CLASS="page_no" data-cite="697 f 3d 95" data-cite-type="PrimaryFederalReporter" data-cite-pageno="95" data-primary-citation="697 F.3d 78">[*95]</span> 
patients through illegal referrals in violation of the Anti-Kickback Act,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEJABE003?jcsearch=42%20usc%201320a-7b&amp;summary=yes#jcite">42 U.S.C. &sect; 1320a-7b</a>. <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X18I3JQ003?jcsearch=517%20f%203d%20449&amp;summary=yes#jcite">517 F.3d at 452</a>. Because of the violation, the
defendant was ineligible to receive Medicare payments. The defendant did not
deny that it had violated the Act, but instead argued that its failure to
disclose information regarding the illegal referrals was immaterial to the
government's decision to approve the hospital's Medicare claims, because
materiality could only be established if a government employee involved in
the decision making process testified that the government would have
terminated payments. <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X18I3JQ003?jcsearch=517%20F.3d%20at%20452&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The court rejected this view of materiality, explaining that a "statement
or omission is `capable of influencing' a decision even if those who make
the decision are negligent and fail to appreciate the statement's
significance." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X18I3JQ003?jcsearch=517%20F.3d%20at%20452&amp;summary=yes#jcite">Id</a>.</i> As the court stated, "[t]he question is not remotely
whether [the applicant] was sure to be caught . . . but whether the omission
could have influenced the agency'<span CLASS="page_no" data-cite="2012 bl 227268 p 17" data-cite-type="Bloomberg" data-cite-pageno="17" data-primary-citation="">[**17]</span> s decision." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X18I3JQ003?jcsearch=517%20F.3d%20at%20452&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In short, even if a program officer does not subjectively consider a
statement to be material, it can be found to be material from an objective
standpoint because it is "capable of influencing" the program officer. <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X18I3JQ003?jcsearch=517%20F.3d%20at%20452&amp;summary=yes#jcite">Id</a>.</i>
As the plaintiff in this case argues, materiality is "determined not by what
a program officer at NIH declares material, but rather [is] based on the
agency's own rules and regulations." PL's Br. at 48.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The <i>Rogan</i> court discussed the purpose of laws prohibiting fraud:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      Another way to see this is to recognize that laws against fraud
    protect the gullible and the careless &mdash; perhaps <i>especially</i> the
    gullible and the careless &mdash; and could not serve that function if
    proof of materiality depended on establishing that the recipient of
    the statement would have protected his own interests. The United
    States is entitled to guard the public fisc against schemes designed
    to take advantage of overworked, harried, or inattentive disbursing
    officers; the False Claims Act does this by insisting that persons
    who send bills to the Treasury tell the truth.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X18I3JQ003?jcsearch=517%20f%203d%20449&amp;summary=yes#jcite">517 F.3d at 452</a> (citation omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We agree with the plaintiff that the test for materiality is an objective
one. It does not require evidence that a program officer relied upon the
specific falsehoods proven to have been false in each case in order for them
to be material. The fact-finder must determine only whether the proven
falsehoods have a "natural tendency to influence, or be capable of
influencing, the payment or receipt of money or property."
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(b)(4)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(b)(4).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To decide otherwise &mdash; that materiality must be established in each case
based on the testimony of a decisionmaker &mdash; would subvert the remedial
purpose of the FCA. The resolution of each case would depend on whether such
a decisionmaker could be identified and located, and whether that particular
person would have treated the claims as material, regardless of whether they
were one of several individuals charged with evaluating the claims at issue.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants' contention would also render the language of the statute
superfluous. If no one other than an actual decisionmaker could determine
whether a statement had a "natural tendency to influence" payment, the
statute could have provided that a statement is "material" if it actually
influenced a decision maker who was aware of the statement.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Our conclusion finds support in other areas of the law. In <i>TSC Indus.,</i>
<i>Inc. v. Northway, Inc.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X2N6LN?jcsearch=426%20us%20438&amp;summary=yes#jcite">426 U.S. 438</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. 2126</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X2N6LN?jcsearch=48%20l%20ed%202d%20757&amp;summary=yes#jcite">48 L.Ed.2d 757</a> (1976),
for example,
<span CLASS="page_no" data-cite="697 f 3d 96" data-cite-type="PrimaryFederalReporter" data-cite-pageno="96" data-primary-citation="697 F.3d 78">[*96]</span> 
the Supreme Court addressed the meaning of "materiality" in the context of a
suit brought under the federal securities laws. The Court determined that a
fact is "material" if there is a "substantial likelihood that a reasonable
shareholder would consider it important in deciding how to vote." <i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X2N6LN?jcsearch=426%20U.S.%20438&amp;summary=yes#jcite">Id</a>.</i> at
448, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. 2126</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      As an abstract proposition, the most desirable role for a court in
    a suit of this sort . . . would perhaps be to determine whether in
    fact the proposal would have been favored by the shareholders and
    consummated in the absence of any misstatement or omission. But as
    we [have] recognized . . . such matters are not subject to
    determination with certainty. <span CLASS="page_no" data-cite="2012 bl 227268 p 18" data-cite-type="Bloomberg" data-cite-pageno="18" data-primary-citation="">[**18]</span> Doubts as to the critical nature of
    information misstated or omitted will be commonplace. And
    particularly in view of the prophylactic purpose of the Rule and the
    fact that the content of the proxy statement is within management's
    control, it is appropriate that these doubts be resolved in favor of
    those the statute is designed to protect.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Id.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The same reasoning applies here. Like the securities laws at issue in <i>TSC</i>
<i>Industries</i>, this objective approach ensures that the FCA serves as a robust
prophylactic against fraud by putting the question of materiality to the
jury, rather than attempting to trace it back to the state of mind of the
decisionmaker.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Bustamante v. First Federal Savings &amp; Loan Association of San Antonio</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XABETK?jcsearch=619%20f%202d%20360&amp;summary=yes#jcite">619 F.2d 360</a> (5th Cir.1980), the plaintiffs alleged that the defendants
violated the Truth-in-Lending Act in a loan transaction. The court noted
that
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      when a security interest [with an exception not relevant here] is
    acquired in real property which is the residence of the person to
    whom credit is extended, the borrower has a right of rescission
    within three business days of either consummation of the transaction
    or "the delivery of the disclosures required under this section and
    all other material disclosures required under this part, whichever
    is later. . . ."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XABETK?jcsearch=619%20F.2d%20360&amp;summary=yes#jcite">Id. at 362</a>. Here again, the court applied an objective rather than a
subjective materiality standard. "[T]o apply a subjective standard to the
test for materiality would misperceive the remedial purpose of the Act."
<i>Id.</i>, at 364. The court concluded that if materiality could be established by
a subjective determination of whether or not particular information would
affect a credit shopper's decision to utilize the credit, unsophisticated or
uneducated consumers would not be sufficiently protected. <i>Id.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Having concluded that the test of materiality in the case before us is
objective &mdash; asking what would have influenced the judgment of a reasonable
reviewing official &mdash; rather than subjective &mdash; asking whether it influenced
the judgment of a reviewer of a proposal in the case at hand &mdash; we agree with
the district court that a reasonable jury could have found the defendants'
statements to be material to the renewal decisions in the third, fourth, and
fifth years of the grant. Based on the stipulations regarding criteria
relevant to funding and the testimony at trial, the jury had an ample basis
for understanding the grant process based upon which it could determine
whether statements that were made or omitted concerning changes to
curriculum, personnel and clinical opportunities in the renewal applications
had a "natural tendency" to influence NIH's funding decisions. The
instructions regarding the grant application and renewal process provided
the jury with a clear understanding of what information the NIH considers in
evaluating progress reports, such as changes or developments to the program.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span CLASS="page_no" data-cite="697 f 3d 97" data-cite-type="PrimaryFederalReporter" data-cite-pageno="97" data-primary-citation="697 F.3d 78">[*97]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants did not inform NIH that not all faculty members identified
in the initial grant were "key personnel" in the program. The defendants
also <span CLASS="page_no" data-cite="2012 bl 227268 p 19" data-cite-type="Bloomberg" data-cite-pageno="19" data-primary-citation="">[**19]</span> failed to inform NIH that several of the core courses listed in the
proposed curriculum were never implemented, and that fellows were never
evaluated by a training committee. NIH was not informed that the fellows did
not have access to research and clinical resources described in the initial
grant application. NIH was also not aware that the fellows had very limited
access to HIV positive patients in their research. In addition, many of the
fellows spent much of their time working on projects unrelated to HIV, such
as research into aging and epilepsy, which was not reported to the NIH. We
conclude that these facts were more than sufficient to allow a reasonable
jury to conclude that had the facts been disclosed they would have had a
natural tendency to influence, or would have been capable of influencing,
the decision to renew the grant and pay money to the defendants pursuant to
it.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We therefore also conclude that the district court did not abuse its
discretion in denying the motion for a new trial &mdash; the jury's verdict was
not "seriously erroneous" or "a miscarriage of justice." <i>Nimely</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XNET90II8BG0?jcsearch=414%20f%203d%20381&amp;summary=yes#jcite">414 F.3d at 392</a> (internal quotation marks omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  III. <i>Exclusion of Evidence Demonstrating NIH's Inaction</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants argue that the district court abused its discretion by
excluding evidence of NIH's alleged failure to take remedial action in
response to the plaintiffs complaints, and that a new trial is therefore
warranted. We review a district court's decision to exclude evidence for
abuse of discretion. <i>Schering Corp. v. Pfizer Inc.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X36C8T?jcsearch=189%20f%203d%20218&amp;summary=yes#jcite">189 F.3d 218</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X36C8T?jcsearch=189%20f%203d%20218&amp;summary=yes#jcite">224</a> (2d
Cir.1999). "We [also] review a district court's denial of a motion for a new
trial for abuse of discretion." <i>United States v. Brunshtein</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X6BECT?jcsearch=344%20f%203d%2091&amp;summary=yes#jcite">344 F.3d 91</a>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X6BECT?jcsearch=344%20f%203d%2091&amp;summary=yes#jcite">101</a> (2d Cir.2003), <i>cert. denied</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X148B1Q003?jcsearch=543%20us%20823&amp;summary=yes#jcite">543 U.S. 823</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=125%20supreme%20court%2035&amp;summary=yes#jcite">125 S.Ct. 35</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=160%20l%20ed%202d%2034&amp;summary=yes#jcite">160 L.Ed.2d 34</a>
(2004).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants contend that they should have been permitted to elicit
evidence of NIH's relative inaction in response to complaints because it is
relevant as to whether or not their statements in the renewal applications
were false and material. Feldman told NIH about the defendants' fraudulent
claims and, according to the defendants, the agency saw no validity to the
complaints as evidenced by its failure to take action beyond asking Cornell
itself to investigate the complaints. The defendants argue that they should
have been able to present this evidence to the jury in an effort to persuade
it that the statements had not misled the agency. If this evidence was
presented, they say, the plaintiff "could then have put on any rebuttal
evidence about why <i>the jury</i> should find the statements were false and
material despite <i>NIH's</i> lack of reaction when presented with those
allegations." Defs.' Br. at 61.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Federal Rule of Evidence <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X135KKI003?jcsearch=Fed.%20R.%20Evid.%20402&amp;summary=yes#jcite">402</a>, provides, <i>inter alia</i>, that "[i]rrelevant
evidence is not admissible." The district court reasoned that the evidence
in question was irrelevant because the NIH's failure to act in response to
Feldman's complaints did not speak to the seriousness of those complaints or
the likelihood that false claims had been made. The jury did not have before
it the standard that NIH used to determine whether or not action was
warranted in response <span CLASS="page_no" data-cite="2012 bl 227268 p 20" data-cite-type="Bloomberg" data-cite-pageno="20" data-primary-citation="">[**20]</span> to a funding complaint. "[N]o discovery was conducted
concerning the standards these agencies employ to determine the existence of
misconduct and whether those standards are at all similar to the elements of
an FCA claim." <i>Feldman III</i>, <cite>2010 WL 2911606</cite>, at *3, 2010 U.S. Dist.
<span CLASS="page_no" data-cite="697 f 3d 98" data-cite-type="PrimaryFederalReporter" data-cite-pageno="98" data-primary-citation="697 F.3d 78">[*98]</span> 
LEXIS 73633, at *7. "Specifically, as to [the plaintiffs] deposition
testimony on the NIH decision, [he] does not, and indeed cannot, speak to
the standards NIH used to judge the merits of his claims." <i><cite>Id</cite>.</i> Without
evidence as to what the standards of the agency were for beginning an
investigation, the jury could not determine whether the complaints made by
Feldman should have instigated one.<a HREF="#fn900" name="fnref_fn900">[fn9]</a><i><cite>Id</cite>.</i>, 2010 WL 2911606, at *2-*3,
<cite>2010 U.S. Dist. LEXIS 73633</cite>, at *7-*8.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants further argue that to the extent that the district court
excluded evidence of NIH's inaction pursuant to <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X135KKK003?jcsearch=Fed.%20R.%20Evid.%20403&amp;summary=yes#jcite">Rule 403</a>, it did so in
error. While ultimately we would be inclined to agree with the district
court, we need go no further in our analysis because the evidence was
properly excluded under <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X135KKI003?jcsearch=Fed.%20R.%20Evid.%20402&amp;summary=yes#jcite">Rule 402</a> in any event. This conclusion was not an
abuse of discretion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>CONCLUSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the foregoing reasons, we affirm the judgment of the district court.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> Because this suit is being brought by Feldman on behalf of the United
States, Feldman is technically the "plaintiff-relator." <i>See</i> infra, note [3].
We nonetheless refer to him simply as the "plaintiff."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> The parties stipulated that of Ryan's 32 clinical patients, two were
HIV positive; of Smith's 35 clinical patients, none were HIV positive; of
Louis's 23 patients, none were HIV positive; of Drake's 48 patients, none
were HIV positive; and of Feldman's 27 patients, one was HIV positive.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> In a <i>qui tarn</i> action, a private plaintiff, known as a relator, brings
suit on behalf of the Government to recover a remedy for a harm done to the
Government. <i>See United States ex rel. Eisenstein v. City of New York</i>,
[<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1B67L4003?jcsearch=556%20us%20928&amp;summary=yes#jcite">556 U.S. 928</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1B67L4003?jcsearch=556%20us%20928&amp;summary=yes#jcite">932</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/1?citation=129%20supreme%20court%202230&amp;summary=yes#jcite">129 S.Ct. 2230</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1B67L4003?jcsearch=173%20l%20ed%202d%201255&amp;summary=yes#jcite">173 L.Ed.2d 1255</a>] (2009) (describing <i>qui</i>
<i>tarn</i> actions under the False Claims Act, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a><i>et seq.); see also</i>
Black's Law Dictionary 1282 (8th ed.2004) (defining "<i>qui tarn</i> action" as
"[a]n action brought under a statute that allows a private person to sue for
a penalty, part of which the government or some specified public institution
will receive"). <i>Qui tarn</i> plaintiffs, even if not personally injured by a
defendant's conduct, possess constitutional standing to assert claims on
behalf of the Government as its effective assignees. There is, however, no
common law right to bring a <i>qui tarn</i> action; rather, a particular statute
must authorize a private party to do so.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Woods v. Empire Health Choice, Inc.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1BDA28003?jcsearch=574%20f%203d%2092&amp;summary=yes#jcite">574 F.3d 92</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1BDA28003?jcsearch=574%20f%203d%2092&amp;summary=yes#jcite">97-98</a> (2d Cir.2009)
(footnote and some citations omitted; second brackets in original).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Where the United States has elected not to proceed with the action, as here,
the relator is entitled personally to recover between 25 and 30 percent of
the proceeds of the action or settlement, plus reasonable attorney's fees.
<i>See</i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUI003?jcsearch=31%20U.S.C.%20%203730(d)(2)&amp;summary=yes#jcite">31 U.S.C. &sect; 3730</a>(d)(2).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> The district court similarly excluded evidence of inaction on the part
of the New York State Department of Education and the American Psychological
Association, but the defendants do not challenge the exclusion of that
evidence on appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> In 2009, Congress amended the False Claims Act to add a specific
requirement that to be actionable a false statement must be material.
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(1)(B)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a)(1)(B). It purports to apply prospectively and therefore
would not apply to this case. <i>See Feldman I</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4855H1?jcsearch=674%20f%20supp%202d%20475&amp;summary=yes#jcite">674 F.Supp.2d at 480</a>. Never
prior to that enactment and absent its materiality provision did we
explicitly require a showing of materiality in FCA cases, although six of
the seven circuits to address the issue did. <i>See <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4855H1?jcsearch=674%20F.%20Supp.%202d%20475&amp;summary=yes#jcite">id</a>.</i> (citing decisions). We
need not decide here whether a showing of materiality was required because,
assuming that it was, the requirement has been met, as we explain in Part
II, below.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> District courts within this Circuit have also employed this
methodology. <i>See United States v. Karron</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XIUVB8N?jcsearch=750%20f%20supp%202d%20480&amp;summary=yes#jcite">750 F.Supp.2d 480</a>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/XIUVB8N?jcsearch=750%20f%20supp%202d%20480&amp;summary=yes#jcite">493</a>
(S.D.N.Y.2011), <i>appeal filed</i>, <cite>No. 11-1924</cite> (concluding that the defendant was
liable for the full amount of a government-funded research grant because he
"cannot establish that the Government received any ascertainable benefit
from its relationship with CASI. Even assuming that CASI in fact met various
milestones and provided reports to the Government, such actions yielded no
tangible benefit to the Government."); <i>United States ex rel.</i>
<i>Antidiscrimination Ctr. of Metro N.Y., Inc. v. Westchester County</i>, <cite>No. 06
Civ. 2860</cite>, [<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1AKFV2003?jcsearch=668%20F.%20Supp.%202d%20548&amp;summary=yes#jcite">668 F. SUPP. 2D 548</a>], 2009 WL 1108517, at *3, <a>2009 U.S. Dist. LEXIS 35041</a>, at *9
(S.D.N.Y. Apr. 24, 2009) ("Westchester has identified no tangible asset or
structure it provided to the United States such that this theory would be
applicable; it did not have a contract with the government to build any sort
of facility for the government's use or to provide it with goods.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> For the reasons referred to in note 5, <i><cite>supra</cite></i>, we assume that
materiality is required by the pre-2009 version of the FCA, although we need
not decide that issue on this appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> The defendants also argue, however, that the district court erred in
interpreting NIH's guidelines as "unambiguous" &mdash; in other words, that to the
extent the plaintiff did point to evidence of materiality, that evidence was
insufficient to support a jury verdict. Defs. Br. at 52. The defendants note
that the renewal application's instructions do not specify what information
needs to be included in a progress report, only that the report should
include "difficulties" with or "changes" to a grant program. <i></i><cite>Id. at 53</cite>. The
instructions do not explicitly state that grantees must report all changes.
Because the NIH guidelines are "necessarily ambiguous," defendants argue
that the court cannot rely upon these guidelines as a "legal standard for
materiality." <i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
But the district court never relied on these guidelines, nor instructed the
jury to rely on these guidelines, as a "standard for materiality." The
guidelines served instead as evidence that the jury was permitted to rely
upon in evaluating what was material to the government in its monitoring of
grants. Therefore, we agree with the district court that they provided
sufficient evidence from which the jury could reach a conclusion as to
materiality. To the extent that these guidelines are ambiguous, it was the
jury's function to resolve any disputes about their meaning.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn900" name="fn900">[fn9]</a></span> The defendants point to <i>United States v. Southland Management Corp.</i>,
<a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X6CHD6?jcsearch=326%20f%203d%20669&amp;summary=yes#jcite">326 F.3d 669</a> (5th Cir.2003) (en banc), where the court considered the
relevance of the course of conduct between a landlord receiving Section 8
funds and HUD. The court concluded that the communication between HUD and
the landlord demonstrated that "HUD was willing to work with the Owners" on
remedying maintenance problems, and that "HUD seemed to recognize that the
property's noncompliance was at least partially explained by a lack of funds
and nearby criminal activity." <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X6CHD6?jcsearch=326%20F.3d%20669&amp;summary=yes#jcite">Id. at 677</a>. Based in part on this pattern of
honest and open communication, the court concluded that there could be no
FCA liability. Unlike in <i>Southland Management</i>, there is no indication here
that the defendants communicated compliance issues to the government or
sought its help in addressing them. Where the government acts in response to
potential false claims, its activity may reveal something about its
understanding as to whether those claims were deliberately false or the
result of extrinsic factors, as in <i>Southland Management.</i> But where, as here,
there is no evidence of government action, nothing relevant can be
ascertained without knowing for which of many possible reasons it did not
act.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
The defendants also cite <i>United States ex rel. Kreindler &amp; Kreindler v.</i>
<i>United Technologies Corp.</i>, <a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4SPTD?jcsearch=985%20f%202d%201148&amp;summary=yes#jcite">985 F.2d 1148</a> (2d Cir.1993), in which we stated
that "government knowledge may be relevant to a defendant's liability." <i></i><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X4SPTD?jcsearch=985%20F.2d%201148&amp;summary=yes#jcite">Id.
at 1157</a>. Indeed it "may be," but is not here where the significance of the
knowledge and the responsibilities of the recipients have not been
established.
</p></div>
</div>
<!--BBLS DD 1725130604547-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1I6KSO003/history">Direct History (3)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1I6KSO003/analysis">Case Analysis (4)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1I6KSO003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
4
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Colleges &amp; Universities</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1Q6LD32KEO2">10-03297 (2d Cir.)</a></div><div class='facetItemLabel'><a href="/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/document/X1Q6LIHBDG82">11-00975 (2d Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Civil Procedure</div><div class='facetItemLabel'>Damages &amp; Remedies</div><div class='facetItemLabel'>Torts</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/61d2a2954b5af725e121ca5ae1d1bdb3/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "61d2a2954b5af725e121ca5ae1d1bdb3";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITYaf46ad&previousPageId=&previousActivityInstanceId=ENTITY7569ec&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:26:04-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1I6KSO003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY7569ec&previousPageId=&previousActivityInstanceId=ENTITYfe6a57&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:26:02-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1I6KSO003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1I6KSO003";
$('#page_loader').show().spin();
JUDGE_IDS=["1842856","1857275","3027922"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
